Publicaciones en las que colabora con Rafael Sirera Pérez (9)

2021

  1. Characterization of circulating t cell receptor repertoire provides information about clinical outcome after pd-1 blockade in advanced non-small cell lung cancer patients

    Cancers, Vol. 13, Núm. 12

2019

  1. Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer

    Cell Death and Disease, Vol. 10, Núm. 9

2017

  1. Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients

    OncoImmunology, Vol. 6, Núm. 1

  2. MicroRNA profiling associated with non-small cell lung cancer: Next generation sequencing detection, experimental validation, and prognostic value

    Oncotarget, Vol. 8, Núm. 34, pp. 56143-56157

2016

  1. Analysis of the immune microenvironment in resected non-small cell lung cancer: The prognostic value of different T lymphocyte markers

    Oncotarget, Vol. 7, Núm. 33, pp. 52849-52861

2014

  1. A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer

    Annals of Surgical Oncology, Vol. 21, Núm. 2, pp. 612-620

2011

  1. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer

    Journal of Thoracic Oncology, Vol. 6, Núm. 2, pp. 286-290

  2. Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

    Clinical and Translational Oncology, Vol. 13, Núm. 6, pp. 411-418

  3. The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients

    Lung Cancer, Vol. 72, Núm. 3, pp. 365-369